Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,307 | -2,198 | -1,281 | -1,029 | 852 |
| Depreciation Amortization | 497 | 1,478 | 1,021 | 670 | 327 |
| Accounts payable and accrued liabilities | 391 | -20 | -469 | 284 | -363 |
| Other Working Capital | 411 | 318 | -111 | 627 | 10 |
| Other Operating Activity | -1,646 | -5,790 | -4,118 | -3,420 | -2,521 |
| Operating Cash Flow | $-1,654 | $-6,212 | $-4,957 | $-2,868 | $-1,696 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -334 | -6,760 | -5,564 | -5,313 | -563 |
| Other Investing Activity | 0 | 1,000 | 1,000 | 0 | 0 |
| Investing Cash Flow | $-334 | $-5,760 | $-4,564 | $-5,313 | $-563 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 6,743 | 6,743 | 6,743 | 6,682 |
| Financing Cash Flow | $N/A | $6,743 | $6,743 | $6,743 | $6,682 |
| Beginning Cash Position | 31,468 | 36,697 | 36,697 | 36,697 | 36,697 |
| End Cash Position | 29,480 | 31,468 | 33,919 | 35,259 | 41,121 |
| Net Cash Flow | $-1,988 | $-5,229 | $-2,778 | $-1,438 | $4,424 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,654 | -6,212 | -4,957 | -2,868 | -1,696 |
| Capital Expenditure | -334 | -6,760 | -5,564 | -5,313 | -563 |
| Free Cash Flow | -1,988 | -12,972 | -10,521 | -8,182 | -2,259 |